Tetanus; the use of human hyperimmune globulin in treatment

N S NATION, N F PIERCE, S J ADLER, R F CHINNOCK, P F WEHRLE, N S NATION, N F PIERCE, S J ADLER, R F CHINNOCK, P F WEHRLE

Abstract

Twenty patients with tetanus were treated with human hyperimmune globulin. The mortality rate in the series was 30 per cent. No complications due to the use of this antitoxin were observed.

References

    1. Am J Public Health Nations Health. 1957 Dec;47(12):1493-501
    1. J Am Med Assoc. 1958 Aug 23;167(17):2062-5
    1. J Am Med Assoc. 1959 Aug 15;170(16):1902-8
    1. Lancet. 1960 Dec 3;2(7162):1229-30
    1. Br Med J. 1962 Jul 14;2(5297):79-81
    1. J Pediatr. 1961 Dec;59:899-902
    1. Surgery. 1950 Jan;27(1):62-73
    1. Bull World Health Organ. 1955;13(3):381-94

Source: PubMed

Sponsorit ja yhteistyökumppanit

Sairaudet

Huumeiden interventiot

3
Tilaa